Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1557-1560

  Nau, Roland ^a   Wellmer, Andreas ^b   Soto, Adriana ^b   Koch, Khristina ^b   Schneider, Olaf ^b   Schmidt, Holger ^b   Gerber, Joachim ^b   Michel, Uwe ^b   Brück, Wolfgang ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; LIPOTEICHOIC ACID; RIFAMPICIN; TEICHOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; DOSE RESPONSE; INFLAMMATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL TIME;

ANIMALS; CEFTRIAXONE; INFLAMMATION MEDIATORS; MENINGITIS, PNEUMOCOCCAL; MICE; MICE, INBRED C57BL; PROBABILITY; RIFAMPIN;

EID: 0033065397     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314760     Document Type: Article

References (14)

1. 1. Burroughs M, Rozdzinski E, Geelen S, Tuomanen E. A structure-activity relationship for induction of meningeal inflammation by muramyl peptides. J Clin Invest 1993;92:297-302.
2. 2. Syrogiannopoulos GA, Hansen EJ, Erwin AL, et al. Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. J Infect Dis 1988;157:237-44.
3. 3. Täuber MG, Shibl AM, Hackbarth CJ, Larrick JW, Sande MA. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis 1987; 156:456-62.
4. 4. Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985;151:859-68.
5. 5. Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis 1989;160:818-25.
6. 6. Nau R, Zysk G, Schmidt H, et al. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis. J Antimicrob Chemother 1997;39:781-8.
7. 7. Schmidt H, Zysk G, Reinert RR, et al. Rifabutin for experimental pneumococcal meningitis. Chemotherapy 1997;43:264-71.
8. 8. Trostdorf F, Reinert RR, Schmidt H, et al. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis. J Antimicrob Chemother 1999;43: 87-94.
9. 9. Stuertz K, Schmidt H, Eiffert H, Schwartz P, Mäder M, Nau R. Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to β-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin. Antimicrob Agents Chemother 1998;42: 277-81.
10. 10. Calleja C, Pascussi JM, Mani JC, Maurel P, Vilarem MJ. The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat Med 1998;4:92-6.
11. 11. Schlüter D, Chahoud S, Lassmann H, Schumann A, Hof H, Deckert-Sehlüter M. Intracerebral targets and immunomodulation of murine Listeria manocytogenes meningoencephalitis. J Neuropathol Exp Neurol 1996;55:14-24.
12. 12. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31.
13. 13. Paris MM, Hickey SM, Uscher MI, Shelton S, Olsen KD, McCracken GH. Effect of dexamethasone on therapy of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1994;38:1320-4.
14. 14. Zysk G, Brück W, Gerber J, Brück Y, Prange HW, Nau R. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 1996;55:722-8.